Othus M

ORCID: 0000-0001-8176-6371 · 1 paper in corpus

2026

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.

Journal for immunotherapy of cancer ·doi:10.1136/jitc-2025-012805

BackgroundDual anti-CTLA-4/PD-1 inhibitors show efficacy in numerous malignancies. We are the first to report on the efficacy of ipilimumab-nivolumab immunotherapy in a dedicated cohort of patients with gynecologic clear cell carcinomas (CC…